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The hostile neck does not increase the risk of
carotid endarterectomy
Mauro Frego, MD, Alessio Bridda, MD, Cesare Ruffolo, MD, Marco Scarpa, MD, Lino Polese, MD, and
Giorgio Bianchera, MD, Padova, Italy
Introduction: Hostile neck anatomy is assumed to be associated with increased surgical risk for patients undergoing
carotid endarterectomy (CEA) and is often considered a reason to choose carotid stenting or medical management. This
retrospective case–control study evaluated whether, and how much, anatomically hostile necks represent a condition of
higher surgical risk of early and late mortality and major or minor morbidity.
Methods: The data for 966 homogeneous CEA patients was prospectively entered in a computer database. Seventy-seven
had a hostile neck anatomy due to previous oncologic surgery or neck irradiation, restenoses after CEA, high carotid
bifurcation, or bull-like and inextensible neck. A case-control matched-pair cohort study considered sex, age (5-year
intervals), and year of operation. Regional anesthesia was used for all operations for atherosclerotic stenosis >70%,
conforming to the European Carotid Surgery Trial (ECST) in symptomatic and asymptomatic patients, at a single center
and by one surgeon or under his direct supervision.
Results: The hostile neck patients and the control group were matched for age, sex, carotid-related symptoms, degree of
stenoses, and main risk factors for cardiovascular diseases. Intraoperative variables were substantially equivalent in the
two groups; however, procedure length and clamping time were, respectively, about 22 minutes (P  .0001) and 7
minutes longer (P  .01) in the hostile neck group. Rates of postoperative mortality and neurologic events were
equivalent. Peripheral nerve lesions were multiple and significantly more frequent in the hostile neck patients (21% with
>1 cranial nerve lesion vs 7% of controls, P  .03), yet all were transient and limited to a few months. The subgroups of
patients with hostile neck, restenoses, and bull-like inextensible necks required the longest operative and clamping time,
and those with bull-like and high bifurcation had the most frequent cranial nerve dysfunctions. At the respective
follow-up of 47 and 45 months, survival curves (P  .48) and the incidence of restenoses and fatal and nonfatal strokes
were similar (5 and 4, respectively).
Conclusions: Hostile necks led to more complex CEA procedures but without substantial consequences in early and late
morbidity and mortality. Most patients with hostile neck can undergo CEA at low risk, with the benefit of effective
long-lasting stroke prevention similar to standard patients. In our opinion, the more frequent but temporary cranial
nerve dysfunctions that occur are not sufficient to consider hostile neck patients noneligible for CEA. (J Vasc Surg 2009;
50:40-7.)Landmark prospective randomized clinical trials have
definitively shown that carotid endarterectomy (CEA) of-
fers a significant therapeutic advantage compared with op-
timal medical therapy, if perioperative mortality and major
morbidity are6% in symptomatic and 3% in asymptomatic
patients.1-4 In reality, patients empirically estimated at high
risk for surgery—particularly for advanced age, comorbidi-
ties, and cervical abnormalities—were excluded from these
and other trials. In the course of the last 15 years, however,
modern medical therapies have substantially improved the
control of atherosclerotic disease by means of statins and
more effective antihypertensive and antiplatelets drugs.5-7
Moreover, carotid angioplasty with stenting (CAS) has
gained a growing and uncontrolled popularity on the as-
sumption that minor invasiveness is equal to minor risk.
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40Unfortunately, some trials have shown unexpected
risks for CAS in some cohorts of patients estimated at high
medical8 and surgical risk; for example, elderly people (Ca-
rotid Revascularization Endarterectomy vs. Stent Trial)9 and
patients with restenoses after CEA.10,11 The Endarterectomy
Versus Angioplasty in Patients With Symptomatic Severe
Carotid Stenosis (EVA-3S) comparative trial was prema-
turely interrupted due to excessive risks in the patients
treated with CAS,12 and the Stent-Supported Percutane-
ous Angioplasty of the Carotid Artery versus Endarterec-
tomy (SPACE) comparative trial concluded that the indis-
criminate widespread use of CAS is not justified.13 Finally,
very recent meta-analyses did not support the superiority of
CAS over CEA.14-18
Thus, in such a confusing situation where clarifying
studies comparing modern treatment modalities are still
awaited, it is worthwhile to ascertain which single category
of patients may benefit more from one kind of treatment or
another, depending on the specific procedural risks. In
particular, patients with altered and unfavorable cervical
anatomy due to previous carotid or oncologic surgery,
cervical irradiation, abnormally high carotid bifurcation,
and very short and inextensible neck, may pose significant
technical challenges in terms of operating technique in-
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tive studies from surgical series have investigated the prob-
lem,11,19-30 but only considered the main early outcomes
of postoperative mortality andmajor neurologic morbidity.
Other periprocedural variables, minor complications, and
late results, such as survival, late neurologic events, and
restenoses disclosing perhaps directly or indirectly a higher
procedural difficulty, have never been properly quantified,
nor have safer and long lasting results been proved for
patients with a hostile neck treated with CAS or medical
therapy.
The purpose of this study was to quantify the effect of
hostile neck anatomy on early and late outcomes of CEA.
To this end we designed a retrospective case–control study
using prospectively gathered data from the computer data-
base of our center’s 20-year experience with CEA.
PATIENTS AND METHODS
A prospective database of patients operated on for
cerebrovascular diseases recorded from 1989 until June
2008 was consulted. From 1246 revascularization proce-
dures, the following were excluded: the first 53 patients
operated on during the first 3 years of surgical activity
because of the learning curve), 182 operated on in consul-
tation at other hospitals with different attending modali-
ties, and 45 CEAs performed during major reconstructions
of supra-aortic trunks because of greater surgical complex-
ity. The remaining 966 CEAs were all performed by the
same senior surgeon or under his direct supervision since
1992, at the same institution and with the same techniques,
although these have obviously evolved during the 16-year
period.
The indication for surgery was atherosclerotic stenosis
70% (conforming to European Carotid Surgery Trial
[ECST]), both in symptomatic and asymptomatic patients,
and50% when an ulcer was clearly evident in a symptom-
atic patient or when the contralateral carotid was occluded.
All surgical procedures were performed with regional anes-
thesia with deep (C2 to C4) and superficial cervical plexus
block or cervical epidural anesthesia in the C7 to T1 inter-
vertebral space (awake patient), the latter being used from
1992 to 1994 during an unpublished comparative study.
The surgical technique followed standard safety rules
entailing the preventive isolation of the hypoglossal nerve,
isolation of the carotid artery without manipulation of the
atherosclerotic plaques, dissection of the carotid bifurca-
tion only after cross-clamping under systemic hepariniza-
tion, the use of a selective shunt based on patient response,
direct visualization of the extremities of the endarterec-
tomy, accurate removal of any residual flaps with the fixa-
tion of a possible distal dissection, and systematic patch
closure after open technique (with possibly a transverse
plication if the endarterectomized artery was excessively
redundant) or reimplantation after the eversion technique.
The patient’s clinical condition was monitored hourly for
the first 24 hours after the procedure, usually in the surgical
ward.The selection criteria used in the present study were as
follows:
1. previous oncologic surgery deeply involving the lateral
neck, with or without radical neck irradiation;
2. carotid restenoses 80% after CEA initially performed
at our center or elsewhere;
3. high carotid bifurcation at the level of the second cervi-
cal vertebra or the angle of the mandible, or the need to
extensively mobilize the hypoglossal nerve with the
section of the occipital branch, or the need to section
the digastric muscle; and
4. the presence of a very short, bull-like or inextensible
neck due to cervical ankylosis requiring a pillow to
sustain the head.
Other anatomic abnormalities were excluded, in partic-
ular (1) low bifurcation traditionally not representing a
challenge to surgery; (2) previous thyroid or parathyroid
surgery regarding only the anterior neck, unless associated
with radical lymphectomy; and (3) contralateral carotid
occlusion and recurrent laryngeal nerve palsy, unlike the
Stenting and Angioplasty with Protection in Patients at
High Risk for Endarterectomy (SAPPHIRE) study,31 be-
cause these conditions represent an adjunct risk not ana-
tomically related to the field of surgery.
A case–control matched-pair cohort study was con-
ducted. All patients satisfying the selection criteria were
placed in the hostile neck group and were consecutively
matched with an equal number of patients randomly cho-
sen out of the possible pool for sex, age (5-year intervals),
and year of operation. Symptoms, degree of stenosis, and
cardiovascular risk factors were not used as matching criteria.
In addition to the database of the selected and control
patients, we reviewed hospital medical records, descriptions
of the surgical procedures from the operative registers, daily
hospital notes, operative discharge summaries (including
notes from the surgeon and medical consultations), and
records from the follow-up, which were planned at 1, 3,
and 6 months, and then yearly. Perioperative outcome
measures included cranial nerve injuries, stroke, transient
ischemic attack, cardiac events, and death occurring 30
days from the procedure.
Clinical signs and symptoms of neurological deficit
were systematically searched in the postoperative period,
carefully described by the operator or the surgeon on call,
and commented on at discharge. Cranial nerve injuries
were defined clinically or after consulting with an otolaryn-
gologist, with or without laryngoscopy. Symptoms such as
ipsilateral lip drop and involuntary drooling were attributed
to dysfunctions in the marginal mandibular branch of the
facial nerve; ipsilateral deviation of the tongue, inarticulate
speech, and clumsy mastication to the hypoglossal nerve;
hoarseness and difficulty coughing effectively to the recur-
rent laryngeal nerve; voice fatigue and loss of high-pitch
phonation to the superior laryngeal nerve; difficulty in
swallowing solid food and nasopharyngeal reflux of fluids
with possible aspiration to the glossopharyngeal nerve; and
sensory loss, paresthesia, and dysesthesia in the inframan-
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nerve. Dysfunctions regressing within the day of operation
were not considered because they were attributed to addi-
tional local infiltrations of anesthetics.
The entity of symptoms was determined at follow-up
according to the patient’s description and the surgeon’s
physical examination. Stroke was defined in terms of a new
neurologic event lasting 24 hours and was classified as
minor (lasting 24 hours and cleared at 30 days), major
(symptoms persisting for1 month), and lethal. Transient
ischemic attack was defined in terms of a new neurologic
focal event from which the patient would completely re-
cover 24 hours. In the case of specific symptoms or
uncertainties, the patient was examined by a neurologist
and underwent computed tomography (CT) scan or mag-
netic resonance imaging (MRI) if necessary. Myocardial
infarction was diagnosed on the occurrence of a new Q-
wave in two leads or the presence of elevated enzymes.
Cardiac enzyme levels and electrocardiogram were rou-
tinely assessed in the postoperative setting and subse-
quently obtained only in response to appropriate patient
signs or symptoms.
The reported long-term outcomes included carotid
bifurcation restenosis, permanent nerve injuries, cardiac
and neurologic events, and death. Late results were ana-
lyzed, and deficits lasting2 years were considered perma-
nent. Restenosis was defined as carotid stenosis30% after
intervention at the follow-up duplex examination, consid-
ering the area of the residual lumen related to the supposed
lumen of the vessel at the level of the stenosis conforming
to ECST. Fatal stroke was defined as death attributed to
ischemic or hemorrhagic stroke. A fatal cardiac event was
defined as death attributed to acute myocardial infarction
or cardiac failure. These events were recognized through
descriptions in the computerized medical records by the
surgeon, neurologist, or otolaryngologist, as well as by
results of head CT or brain MRI.
Patients whose last follow-up dated back 1 year were
contacted by phone and recalled for ambulatory clinical and
duplex examination. Information on dead patients or those
lost to follow-up was obtained through relatives, a family
doctor, or the registry office.
Data were processed using theOpen Stat 4 software (by
Bill Miller, Iowa State University). The two groups were
compared with the t test for continuous data and the 2 test
for categoric data. The Kaplan-Meier analysis was used for
the survival rate, and survival curves were compared with
the log-rank test. The level of significance was assumed as P
 .05.
RESULTS
Patients. We identified 77 patients as having hostile
neck and divided them into four main subgroups:
● 11 patients with previous oncologic surgery, consist-
ing of 5 total laryngectomies with tracheostomy, 1
homolateral hemilaryngectomy, 2 tracheostomies, 2
tracheostomies with radical lymphectomy, and 1 radi-cal neck dissection, 8 of whom also underwent radical
neck irradiation;
● 23 redo carotid surgery patients, of which 22 were for
restenoses and 1 for pseudoaneurysm after CEA pri-
marily performed at our surgical unit and elsewhere;
● 35 high bifurcations; and
● 8 markedly short, bull-like or inextensible necks con-
sidered as one group because of similar problems dur-
ing dissection and vascular exposure.
Patients with hostile neck anatomy were statistically
equivalent to the control group in age, gender, symptom
status, degree of stenosis, and cardiovascular risk factors
(Table I).
Operative details. A comparison of operative data for
the hostile neck anatomy groups and control patients is
summarized in Table II. No statistically significant differ-
ences were noted in anesthetic management, operative
technique, carotid reconstruction techniques, shunt re-
quirement, blood loss, or hospital stay. Significant differ-
ences were, however, noted in total operative and clamp
time.
Perioperative outcome (Table III) was equivalent in
the two groups. Only dysfunctions due to cranial nerve
injuries or their branches were significantly more frequent
and longer lasting in the hostile neck patients. Neverthe-
less, all lesions were temporary and, above all, with no
clinical consequence. The number of cranial nerve injuries
per patient was significantly higher in the hostile neck
group.
Late outcome. Detailed data were collected for an
equivalent number of patients and for a similar follow-up
period in the two groups (Table IV). The log-rank test
showed no statistical difference in survival between the
groups (Fig). Fatal neurologic and cardiac death rates were
similar for the two groups, and all strokes were ischemic
except one hemorrhagic stroke in the hostile neck group.
Late nonfatal neurologic events were also statistically simi-
lar. No restenosis progressed to 50%.
Analyses for the subgroups. When the four sub-
groups of hostile neck patients were considered separately,
analyses showed that the outcome of patients with previous
oncologic surgery or neck radiation was very similar to the
control group (Table V). Restenoses and bull-like inexten-
sible necks required the longest operative and clamping
times, and bull-like necks and high bifurcation had the
most frequent cranial nerve dysfunctions.
DISCUSSION
A consistent definition of “hostile” neck does not exist
yet, and the concept of “technically difficult” is largely
subjective. Nevertheless, in surgical practice, anatomic ab-
normalities (physiologic or pathologic, acquired or con-
genital), fibrosis secondary to surgery, and infections or
irradiation may result in a more difficult dissection with
possible injury to surrounding tissues, particularly the cra-
nial nerves and other cervical branches of the somatic
nerves. Similarly, more vascular manipulation and limited
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thromboembolic complications and suboptimal recon-
struction. Finally, prolonged anesthesia and procedural
time may be followed by systemic complications.
Our study has two major limitations. First, because our
data are drawn from a single institution’s experience, our
results and conclusions may not pertain to other practice
settings. Second, we had relatively small numbers of pa-
tients with hostile neck anatomy and low adverse event
rates, and so are unable to detect small outcome differences
should any exist.
According to our inclusion criteria, approximately 7%
of carotid stenoses amenable to surgery may reside in a
hostile neck. Our intraoperative data generally show sub-
stantial equivalence between patients with hostile neck and
standard patients. Mean operative time was significantly
longer (22 minutes) in the studied group, although this
Table I. General data and cardiovascular risk factors in th
Variable Hostile necks
Total patients, No. 77
Symptomatic at diagnosis 50
Male/female (ratio) 51/26 (1.96:1
Age, y
Mean  SD 69.7  7.6
Median (range) 70 (55-92
Lipidemia, No.
No data 9
Absent 36
Hypertriglyceridemia 2
Hypercholesterolemia 18
Mixed 12
Diabetes mellitus, No.
No data 3
Absent 50
Diet control 12
Oral hypoglycemic therapy 9
Insulin therapy 3
Systolic pressure, No.
No data 5
150 mm Hg 45
150 mm Hg 26
Abnormal 1
Smoking, No.
No data 12
Absent 22
1-10 cigarettes/d 1
10-20 cigarettes/d 2
20 cigarettes/d 8
Ex-smoker 32
Cardiac diseases, No.
No data 1
Absent 32
Valve disfunction 5
Myocardial infarction 11
Angina 7
Serious cardiac dilatation —
Arrhythmia 2
Altered conduction 8
Hypertensive cardiomyopathy 11
Other . . .does not seem to be crucial in increasing the physiologicrisks. The difference is more attributable to vessel dissection
than to the endarterectomy and reconstruction phase, al-
though a slightly longer clamping time (8 minutes) was
reported.
These data are confirmed in the restenosis, high
bifurcation, and bull-like and inextensible neck sub-
groups, for which operating time was respectively 27, 18,
and 35 minutes longer than that of the control group. In
particular, the high bifurcation and bull-like and inex-
tensible neck subgroups usually required a more exten-
sive dissection, with mobilization of distal structures
such as the hypoglossal nerve, ligation of the occipital
branch of the external carotid artery, and occasionally,
division of the digastric muscle, fracture of the styloid
process, and subluxation of the mandible. Only patients
with restenoses reported longer cross-clamping time,
suggesting a more difficult or complex endarterectomy
groups
Controls P (t or 2 test)
77
55 .38
51/26 (1.96:1) . . .
.85
69.5  6.5
70 (51-82)
.29
8
25
5
29
10
.91
5
50
11
7
4
.85
4
49
24
. . .
.96
9
23
3
2
8
32
.21
5
26
2
17
4
4
3
4
9
3e two
)
)and reconstruction.
PTFE, Polytetrafluoroethylene.
aStatistical significance set at P  .05.
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Complication Hostile necks Controls P (t or 2 test)a
Patients, No. 77 77
Deaths, No. 1b 1b . . .
Congestive heart failure, No. 1c 1c . . .
Transient ischemic attack, No. 1 1 . . .
Stroke, minor, No. 1 0 .15
Redo surgery for hematoma, No. 2 . . . .31
Cranial nerves dysfunction, No. 24 in 16 pts 7 in 5 pts .82
Symptoms duration, mon
Mean  SD 4.6  5.5 4.1  2.4
Median (range) 2 (1-27) 3 (2-8)
Nerve dysfunction duration, median (mean  SD)
Facial, mandibular branch 3 (1.5  0.5) 1 .31
Superior laryngeal 2 (1.3  0.5) . . . .31
Deglutition deficit 8 (4.1  3.3) 2 (4.0  2.8) .04
Recurrent laryngeal 5 (3.0  2.4) 1 .02
Hypoglossal 6 (8.8  8.5) 3 (5.5  2.1) .31
Nerves involved per patient
None, No. (%) 61 (79.2) 72 (93.6) .03
One nerve, No. (%) 8 (10.4) 3 (3.8)
Two nerves, No. (%) 8 (10.4) 2 (2.6)
aStatistical significance at P  .05.
bBoth deaths were a result of myocardial infarction.Table II. Type of anesthesia and surgical procedure
Variable Hostile necks Controls P (t or 2 test)a
Patients, No. 77 77
Anesthesia, No. .48
Deep, superficial plexus block 67 62
Cervical epidural, interscalenic, local 8 14
Conversion to general 2 1
Carotid endarterectomy, No. .97
Open technique 47 47
Eversion technique 26 27
Resection 4 3
Reconstruction, No. .39
Direct closure 3 2
Vein patch 6 1
PTFE patch 8 8
Dacron patch 35 36
Bypass/other 1 4
Reimplantation 24 26
Need for selective shunt, No. 8 8 . . .
Operative time, min
Mean  SD 128.9  35.2 106.1  28.4 .0001
Median (range) 120 (70-220) 100 (60-180)
Clamping time, min
Mean  SD 52.3  20.1 45  15.2 .01
Median (range) 50 (20-120) 40 (20-95)
Blood loss, mL
Mean  SD 120.6  179.5 104.4  154.8 .58
Median (range) 50 (10-1000) 50 (10-900)
Post-op hospital stay, d
Mean  SD 4.1  2.3 4.1  2.2 .44
Median (range) 4 (2-13) 4 (2-12)cBoth events were failures.
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with or without associated irradiation, had an overall oper-
ating time equal to controls, indicating that the CEA
procedure is only marginally affected by previous laryngec-
tomy, tracheostomy, or radical neck dissection. In this
context, the exact role of neck irradiation cannot be de-
duced because this has been nearly always associated with
surgery. Furthermore, operative blood loss and the need
for reoperation for hematoma are comparable, suggesting
that the anatomic abnormalities being considered do not
increase the risk of hemorrhage, even though we did not
usually neutralize systemic heparinization after clamping
release.
Mean hospital stay is equivalent and may appear very
long when taking into consideration present hospital dis-
charge times. This is mainly due to the long period covered
by this series. In fact, during the first years of the study,
patients remained in the hospital until the cutaneous
stitches were removed. At present, patients are usually
discharged on postoperative day 2, after skin clips are
removed and replaced by Steri-Strips (3M, St. Paul, Minn);
therefore, the current postoperative hospital stay is about
Table IV. Long-term mortality and morbidity
Variable Hostile necks Controls P (t or 2 test)a
Patients, No. 75/77 74/77
Follow-up, mon
Mean  SD 47.3  37.5 45.2  39.2 .74
Median (range) 40 (0-156) 40 (0-193)
Mortality, No. 12 15 .52
Stroke 2 3
Cardiac events 4 7 .76
Noncardiovascular 6 6
Morbidity, No.
(timing)
Nonfatal strokes 3 (36 mon) 1 (72 mon) .31
TIAs 1 (11 mon) 1 (1 mon) . . .
Nonfatal cardiac
events 5 (35 mon) 7 (45 mon) .17
Restenosis 50% 1 (30 mon) 2 (45 mon) .55
TIA, Transient ischemic attack.
aStatistical significance at P  .05.
Fig. Kaplan-Meier survival curves for the hostile neck group (red
line) and the control group (blue line) are presented with the 95%
confidence intervals (gray lines). Log-rank P  .78.36 to 40 hours.With the above-mentioned limitations of the present
study, postoperative data indicate equivalence for death
and cardiac and central neurologic events 30 days from
the operation. Adverse events reported in both groups are
much less frequent than the accepted standard for this
surgery1-4 according to other retrospective studies from
single series.20,21,24-30 In particular, two postoperative
deaths were due to cardiac complications, and no lethal or
major stroke was reported in the study or control group.
These are in fact the main evaluation criteria being consid-
ered in major international studies comparing CEA with
optimal medical therapies and more recently with CAS.
Only temporary cranial nerve dysfunction was significantly
more frequent (20.8%) and more frequently involved two
nerves (10.4%) when the hostile neck group was compared
with the control group. High bifurcations and bull-like or
inextensible necks proved to be the anatomic conditions
leading to the highest risk for cranial nerve injuries.
Lesions were likely due to excessive retraction or elec-
trocautery in a narrow surgical field. Almost all dysfunc-
tions were limited to minor functional impairments such as
tongue or mouth deviation, difficulty in deglutition and
drinking, and hoarseness. Although in our global series we
observed at least twomajor and definitive lesions, all lesions
of the patients reported here resolved in a few weeks or
months—with the exception of 27 months for a tongue
deviation— and no major complication such as aspiration
was reported.
Cranial nerve palsy after CEA has been reported with
extremely variable rates in various series, probably indicat-
ing different detection methods, and is usually considered
minor and transient. A very recent literature review calcu-
lated a 9% mean risk (range, 2%-27%) of temporary palsy,32
and two large, recent collective series reported a similar rate
of somewhat higher than 5%, with only 0.5% lasting more
than a few months.23,33 Outside of standard conditions,
cranial nerve deficits may be more frequent. In another
recent series, 26 lesions were observed in 19 of 89 patients
who underwent reoperations for restenosis.22 In irradiated
necks, soft-tissue fibrotic changes and more extended ath-
erosclerotic lesions34-37 probably explain a greater risk of
peripheral nerve lesions, as reported in two small series of
11 and 14 patients treated with CEA, in whom no central
neurologic events were reported.26,27 Only sporadic radia-
tion lesions were treated with CAS however,38-41 thus
precluding a comparison between surgical and endovascu-
lar treatments of radiation-induced carotid stenosis.
High bifurcations may raise greater problems in ade-
quately exposing the distal internal carotid artery and ob-
taining an optimal distal endarterectomy before reconstruc-
tion. A recent anatomic study confirmed that in this
situation, the hypoglossal nerve would pass very close to the
carotid bifurcation.42 Nevertheless, in small groups extrap-
olated from large surgical series, unfavorable results were
not reported in these patients.29,30 To our knowledge, no
reports have been published regarding very short, bull-like
and inextensible necks.
as th
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nearly 4 years of follow-up are very similar in the two
groups. Particularly, the subgroup with previous oncologic
surgery and radiotherapy did not present an exceedingly
high cancer-related mortality, confirming the suitability of
surgery in these patients with a possibly reduced life expect-
ancy. The rate of late fatal strokes and minor nonfatal
strokes in the hostile neck patients showed no statistically
significant differences compared with the control patients:
all events occurred 3 to 5 years after surgery. In the sub-
group analysis, an excessive 12.5% risk of late stroke seems
to be clear in the bull-like and inextensible neck subgroup
(P  .04), although these events were not related to any
duplex-detected carotid lesion. However, conclusions
drawn from these subgroup data are suspect because of the
very small numbers of subjects and events in each sub-
group.
CONCLUSIONS
Nearly all variables examined indicate substantial equiv-
alence in early and late outcomes in our practice when CEA
patients with and without hostile neck anatomy are com-
pared. Our findings lead to the conclusion that a hostile
neck should not necessarily disqualify patients from consid-
eration for CEA. An increased frequency of cranial nerve
injuries was noted in the hostile neck group, but it is
questionable whether morbidity related to cranial nerve
injury is sufficiently compelling to direct patients with
hostile necks toward carotid stenting or medical manage-
ment.
Carotid restenosis, prior cervical oncologic surgery
Table V. Analyses of the subgroups compared with the co
Variablea
Previous
surgery Pb Rest
Total patients 11 2
Operation time, min 114.3  30.8 .09 133.5
Clamping time, min 45.2  8.2 .97 58.1
Need for shunt . . . .26
Blood loss, mL 74.2  144.6 .62 126
Clamping time, min 45.2  8.2 .97 58.1
Hospital stay, d 4.7  3.4 .35 3.4
Cranial nerve dysfunction, No.
Facial, mandibular branch . . . .70
Superior laryngeal . . . . . .
Deglutition deficit 1 .26
Recurrent laryngeal 0 .70
Hypoglossal 1 .44
Nerves per patient
None 10 .44 1
One . . .
Two 1
Stroke (timing) . . . .70 2 (47
TIA (timing) . . . .70 .
Cardiac events (timing) . . . .29 .
Restenosis 50% (timing) . . . .58 1 (30
aContinuous data are presented as mean  SD; categoric data are presented
bStatistical significance set at P  .05.with and without associated radiation therapy, high carotidbifurcation, and a short or inextensible neck represent
frequently encountered conditions that render CEA more
complex and lead to longer surgical time. In our practice,
however, these conditions do not result in an increase in
major perioperative morbidity or mortality. Our data sug-
gest that most patients with hostile neck anatomy can
undergo CEA with an acceptably low risk for early or late
complications and that the benefit of CEA in providing
effective and durable stroke prevention is not compromised
in these patients.
Well-trained and experienced surgeons should not con-
sider hostile neck anatomy a contraindication to CEA.
Cranial nerve injury is the only adverse outcome signifi-
cantly more common in patients with hostile neck anat-
omy, and such injuries are usually transient. Obviously, the
increased risk of such injuries should be thoroughly dis-
cussed with all patients scheduled for CEA, especially those
with hostile neck anatomy.
We are particularly grateful to Claudio Campagnaro for
his careful English language revision.
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